Premaitha Launch Non-Invasive Pre-natal Screening Test

Premaitha Launch Non-Invasive Pre-natal Screening Test

Pregnant women in the North West can access a new non-invasive pre-natal screening test (NIPT) for Down’s syndrome from today. This follows a deal between Manchester-based Premaitha Health – developer of the IONA test – and private ultrasound and pregnancy screening clinic group This Is My Ltd.

The specific advantage of the IONA test is that pregnant women in the UK can now receive the information they need to make informed decisions in a much shorter timeframe, thereby reducing anxiety. The blood sample can be analysed in local UK laboratories rather than having to be shipped to the US or China. As a result, the waiting time from blood sample to result is only five days, compared to up to two weeks for samples sent abroad.

Managing director of This Is My Judith Pilling said: “This agreement establishes This is My as one of the first private companies in the UK to offer Premaitha’s ground-breaking IONA test. We are very pleased to partner with another UK company to deliver what we consider to be the gold-standard in non-invasive prenatal screening to our clients.”

See article in full at

Important information

This information is of a general nature and does not constitute an offer to provide services.

The opinions and conclusions given here are those of Seneca Partners and are subject to change without notice.

The value of investments and/or any income arising from them may fluctuate.

Past performance is not necessarily a guide to future performance.

Important notice

The products and services shown on this website place capital at risk. Investors may receive less in returns than they have invested. Investments may not allow for capital to be withdrawn on demand. If an investment provides tax relief then this relief is subject to change and is dependant on personal circumstances. Any reference to past performance or forecasted performance is not a reliable indicator of future performance.

Seneca Partners recommends that any investor seeks specialised financial and/or tax advice before investing. Seneca Partners does not provide advice and the information on this website, including but not limited to news, should not be construed as such.

Please confirm that you understand this warning and wish to proceed.